End-of-day quote
Other stock markets
|
||
- GBX | - |
05-02 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
05-02 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Sales 2024 * | 48.96B 66.99B | Sales 2025 * | 50.79B 69.49B | Capitalization | 198B 271B |
---|---|---|---|---|---|
Net income 2024 * | 10.29B 14.08B | Net income 2025 * | 12.05B 16.48B | EV / Sales 2024 * | 4.32 x |
Net Debt 2024 * | 12.88B 17.62B | Net Debt 2025 * | 11.28B 15.43B | EV / Sales 2025 * | 4.13 x |
P/E ratio 2024 * |
19.3
x | P/E ratio 2025 * |
16.5
x | Employees | - |
Yield 2024 * |
3.71% | Yield 2025 * |
3.85% | Free-Float | 85.22% |
Latest transcript on NOVARTIS
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
1st Jan change | Capi. | |
---|---|---|
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
-11.12% | 189B | |
-3.40% | 157B | |
+8.08% | 149B |
- Stock Market
- Equities
- NOVN Stock
- 0HKE Stock